Feds question viability of asset sale in Aetna-Humana antitrust trial

The Justice Department hammered away in court Thursday at the viability of a plan by Aetna Inc. and Humana Inc. to sell off assets to alleviate antitrust concerns about their proposed $34 billion merger.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.